Department of Cardiac Surgery, Montreal Heart Institute, Universite de Montréal, Montreal, Québec, Canada.
Can J Cardiol. 2013 Dec;29(12):1569-76. doi: 10.1016/j.cjca.2013.08.009.
The Ross procedure, which consists of replacing the aortic root with a pulmonary autograft, is the only surgery that ensures long-term viability of the aortic valve substitute. The presence of a living valve in the aortic position was theorized to translate into improved clinically relevant outcomes. This has now been confirmed by a number of recently published studies, which highlight the benefits associated with this surgery in terms of survival, quality of life, hemodynamic characteristics, and freedom from valve-related complications. Nevertheless, despite the evidence, the Ross procedure remains largely underused and has even been abandoned by a large number of groups based on some real and sometimes justifiable concerns, and a number of unfounded biases. The aim of this article is to provide a comprehensive, evidence-based review of the current literature pertaining to the Ross procedure, with an emphasis on the rationale, results, technical key points, alternatives, and future directions.
罗斯手术，即使用肺动脉瓣作为替代物来替换主动脉根部，是唯一能确保主动脉瓣替代物长期存活的手术。理论上，在主动脉位置使用活瓣可以转化为改善临床相关结局。最近发表的多项研究证实了这一点，这些研究强调了这种手术在生存率、生活质量、血流动力学特征和免于瓣膜相关并发症方面的益处。然而，尽管有证据支持，罗斯手术的应用仍然非常有限，甚至已经被许多团体放弃，这些团体基于一些真实的、有时甚至是合理的担忧以及一些毫无根据的偏见。本文的目的是提供一个全面的、基于证据的罗斯手术的当前文献综述，重点是手术的原理、结果、技术要点、替代方案以及未来方向。
